Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.33% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.58% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Humana
HUM
$47.8B
| $892M | 1.05% |
3,660,100
+929,000
| +34% | +$228M |
|
2
Gilead Sciences
GILD
$165B
| $829M | 0.98% |
10,230,899
-176,949
| -2% | -$13.5M |
|
3
Amgen
AMGN
$198B
| $730M | 0.86% |
3,917,700
+517,555
| +15% | +$91.7M |
|
4
NVIDIA
NVDA
$5.02T
| $717M | 0.84% |
160,404,000
-29,947,720
| -16% | -$125M |
|
5
NetEase
NTES
$82.9B
| $708M | 0.83% |
13,415,250
-214,750
| -2% | -$12.3M |
|
6
Colgate-Palmolive
CL
$72.4B
| $700M | 0.82% |
9,604,100
-149,300
| -2% | -$10.8M |
|
|
NVO
7
Novo Nordisk
NVO
$218B
| $691M | 0.81% |
28,722,600
+1,654,000
| +6% | +$37.4M |
|
8
Bristol-Myers Squibb
BMY
$124B
| $691M | 0.81% |
10,846,600
-2,641,600
| -20% | -$154M |
|
9
Domino's
DPZ
$10.9B
| $640M | 0.75% |
3,222,300
+161,400
| +5% | +$31.4M |
|
10
VeriSign
VRSN
$25.3B
| $629M | 0.74% |
5,909,776
+864,300
| +17% | +$87M |
|
11
PepsiCo
PEP
$184B
| $613M | 0.72% |
5,500,700
-142,000
| -3% | -$16.4M |
|
|
12
Johnson & Johnson
JNJ
$599B
| $560M | 0.66% |
4,306,200
-1,826,000
| -30% | -$242M |
|
13
Palo Alto Networks
PANW
$279B
| $533M | 0.63% |
22,187,400
+9,303,600
| +72% | +$212M |
|
|
14
Medtronic
MDT
$107B
| $498M | 0.59% |
6,397,513
+5,963,513
| +1,374% | +$495M |
|
15
Crown Castle
CCI
$34.1B
| $491M | 0.58% |
4,914,000
+38,497
| +0.8% | +$3.94M |
|
16
Cboe Global Markets
CBOE
$29.1B
| $472M | 0.56% |
4,389,700
+19,704
| +0.5% | +$1.94M |
|
17
Walmart Inc
WMT
$878B
| $472M | 0.56% |
18,129,000
+2,939,700
| +19% | +$77.1M |
|
|
BCR
18
DELISTED
CR Bard Inc.
BCR
| $455M | 0.54% |
1,418,500
+122,900
| +9% | +$39.3M |
|
19
Intuitive Surgical
ISRG
$124B
| $448M | 0.53% |
3,857,400
+1,093,500
| +40% | +$119M |
|
20
Home Depot
HD
$332B
| $434M | 0.51% |
2,652,800
+773,400
| +41% | +$119M |
|
|
21
Netflix
NFLX
$286B
| $385M | 0.45% |
21,236,000
+15,043,000
| +243% | +$262M |
|
22
GSK
GSK
$102B
| $383M | 0.45% |
7,550,160
+79,760
| +1% | +$4.05M |
|
23
Align Technology
ALGN
$12.5B
| $379M | 0.45% |
2,037,200
+449,519
| +28% | +$77M |
|
24
Chubb
CB
$138B
| $371M | 0.44% |
2,600,761
+196,300
| +8% | +$28.4M |
|
|
25
Mastercard
MA
$476B
| $353M | 0.42% |
2,500,100
-1,903,800
| -43% | -$252M |
|
Similar funds
Renaissance Technologies's Q3 2017 Portfolio in Review
As of Q3 2017, Renaissance Technologies held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Renaissance Technologies deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Renaissance Technologies's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Renaissance Technologies added most to Medtronic in Q3 2017, an estimated $495M increase.
- Renaissance Technologies's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Renaissance Technologies fully exited Amazon in Q3 2017, selling an estimated $290M.
- Renaissance Technologies's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Renaissance Technologies opened 418 new positions and closed 418 in Q3 2017.
- Renaissance Technologies's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.